The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

Shares of AstraZeneca PLC AZN rallied 1.18% to £111.80 Monday, on what proved to be an all-around positive trading session ...

White-collar lawyer and former U.S. attorney Neil MacBride has rejoined Davis, Polk & Wardwell following a two-year stint as ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

At the Capability Leaders Forum, marketers from AstraZeneca, Reckitt and Trainline discussed the potential of genAI to ...

Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...

Secretary of State for Science, Innovation and Technology Rt Hon Peter Kyle and Minister of State for Science, Research and ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

MULTINATIONAL pharmaceutical firm AstraZeneca (AZ) wants to conduct the majority of its clinical trials in the Philippines, ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...